Mitroflow Aortic Bioprosthesis 5-Year Follow-Up: North American Prospective Multicenter Study

The Mitroflow valve implanted in the aortic position has shown to be hemodynamically stable over a 5-year follow-up in an elderly population with a high prevalence of comorbid conditions.